Octreotide’s efficacy in managing intrathoracic chyle leak post-esophagectomy in adults was investigated in a cohort study. Among 74 patients, 27 received octreotide, but there was no significant difference in chest tube duration, hospital length of stay, or overall survival compared to non-octreotide group. Multivariable analysis confirmed that octreotide did not affect clinical outcomes. The study concludes that octreotide lacks evidence for improving outcomes in adult patients with chyle leak post-esophagectomy, highlighting the need for further research.
Journal Article by Deboever N, Feldman H (…) Hofstetter WL et 10 al. in Dis Esophagus
© The Author(s) 2024. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.